Feature / New world optimism

03 November 2010

Login to access this content

Department of Health deputy chief executive David Flory insists a strong NHS finance function is vital to the government’s vision for the NHS. Steve Brown reports

Finance staff in primary care trusts and strategic health authorities, and other support function colleagues, face major uncertainty in the transition to the ‘new world’ NHS set out in this summer’s white paper. Challenging management cost reductions will mean cuts in the short term in support functions. But with no detailed central blueprint for how consortia should look or operate, there is a fear finance staff may feel compelled to look for other career opportunities. And in the longer term vital finance skills will be lost to the NHS.

But, speaking exclusively to Healthcare Finance, the Department of Health’s financial leaders – David Flory, deputy chief executive and director general of NHS finance, performance and operations, and Bob Alexander, director of NHS finance – have made it clear that financial management is top of their agenda.

‘We are absolutely determined we are not going to get to the other side of implementing the white paper with an inadequate finance capability,’ says Mr Flory. ‘We are just not going to let that happen. An important part of us discharging our roles in this period is to ensure the new world is set up to deliver its objectives. It can only do that with the very best standards of financial management and capacity.’

He points to the significant improvement in recent years in NHS financial performance demonstrated again in the auditors’ local evaluation and use of resources scores (see page 13). ‘We are just not going to let that go by not paying proper attention,’ he says. ‘We will do everything we can to make sure the finance profession remains strong – and gets even stronger – through this period of change.’

Both Mr Flory and Mr Alexander say there is a logic to assuming an important role for a strong finance function. The white paper’s vision is built on maintaining control over resources and driving even better value for taxpayers’ money. And whatever the final configuration of new GP commissioning consortia and commissioning board, with whatever national and local structure, there is still £100bn to be managed, controlled, invested and accounted for.

‘The people in existing structures have, with their boards and partners locally, driven the improvement  we’ve seen in recent years,’ says Mr Flory. ‘That work still needs to be done.’

There can, however, be no guarantees. ‘I can’t say – and it would be completely wrong to say – that there is a job for everybody in the new world. The management cost reductions are real and need to be made. But there is a path for a lot of people and I hope a lot of people will make the transition to keep doing what they are doing because we need their capability in the way we’ve benefited from in recent years.’

He admits he is ‘concerned about retaining our people’ and promises more detail soon on how the new structures will operate, so people will be able to see their route in.

Mr Alexander underlines the message. ‘What we can do is to paint a compelling picture for finance staff. Financial control and the quality of financial management must be something we hold on to,’ he says. He too points to the white paper as evidence of the importance attached to financial management. ‘There will be some type of accreditation process,’ he says, ‘whereby consortia will need to have to demonstrate their ability to manage and get best value out of the resources at their disposal. Financial management capability will be pretty crucial in that accreditation view.’

Mr Alexander says he’d be ‘surprised’ if there were not some form of risk metrics approach taken with consortia. ‘Will it look like the Monitor regime? I don’t know. Would it use similar principles? Possibly. Will there be a backward-looking assessment? Clearly, we are still looking at the audit arrangements  for consortia, but in any audit arrangements I’d want auditors to give some view on the financial standing of a consortium.’

Size of finance function

As to how many finance staff will be needed, Mr Alexander stresses that the quantum of money hasn’t changed and activities that would be expected to be undertaken to manage, control and account for that money won’t change much either.

‘Some of the big things that need to be done don’t alter because we are changing the superstructure,’ he says. Some existing PCT finance staff will move with provider arms as part of the transforming community services changes. And finance will clearly take some of the hit on management cost reductions.

But the exact make-up of the finance function within commissioning will be dictated by the final structure of consortia and their decisions on how to operate. ‘I could see chains of consortia coming together to get all their business support from a shared function,’ he adds. ‘Or I could easily see a chief finance officer with a virtual team covering multiple consortia. Or an astonishingly large consortium justifiably having its own bespoke finance function.’

Echoing Mr Flory, he says the Department is determined the NHS will not take a backwards step on financial management. ‘We have a good legacy that no one wants to lose,’ he says.  ‘After all, you don’t want it to be your piece of jigsaw that gets lost down the back of the sofa.’

Spending review

Given the pain in the public sector of last month’s spending review, the NHS can only view its position as fortunate. Real terms increases over the four years – albeit a minimal 0.1% annual uplift – compare to significant real terms cuts in other departments. But those in the NHS know it still faces a gargantuan challenge in delivering £15bn-£20bn of productivity improvement in the next period.

‘The coalition government has been clear in its commitment to protect health money and the spending review has delivered that. It is what we expected and we appreciate we are in a situation that is relatively much stronger than other parts of government,’ says Mr Flory. ‘But the fact is that the cash uplift year on year for us now is significantly lower than we’ve experienced. That presents a significant challenge for the NHS in planning and delivering in 2011/12 and beyond.’

There are additional risks for the NHS in the broader settlement for the public sector – principally in the potential impact of cuts in social services funding. A transfer of NHS capital to fund measures that support social care, building up to £1bn in 2014/15, aims to address this risk in a proactive way.

‘If you take out police, fire and schools, it is a real reduction of 26% in local government,’ says Mr Flory. ‘So it was really important we recognised the way social care and healthcare are enjoined.’ 

Part of the £1bn will be the already identified reablement funds, which will rise to £300m. ‘What is really important is that the remainder goes through PCTs so it brings them together with council social care providers – joining up their priorities and money in meeting the needs of people locally. We know if we don’t contribute in this way there’d be a washback to us in delayed discharges and other pressures that we’d pay for anyway. So [this] enables us to be partners with local government in getting this right.’

Mr Flory is also categorical on the issue of the position of NHS revenue surpluses. ‘The deal between the Department and the NHS is unchanged. We are not in the game of saying you’ve had this surplus, we are not going to carry it forward. That is simply not the situation,’ he says.

The creation of non-recurring surplus in PCTs, with PCTs allowed to draw it down in a managed way, has been a key part of the NHS’s strategy to manage financial risk. This year’s target of £1bn ‘feels about right’ in overall terms, says Mr Flory.

But he says that, as the service moves into tighter times, new approaches are needed to manage risk. The current surplus is ‘lumpy’ – not shared by all PCTs. ‘What we need going forward is for every PCT to have that non-recurring headroom. That’s how we deal with financial uncertainties.’

He says that the non-recurring surplus brought forward is ‘still important to us’. This year he expects PCTs to continue to draw down against the accumulated surplus and the Department is comfortable with that.

‘But I have not got a queue of PCTs knocking my door down saying: “Give us our money, you are stopping us spending it”. They recognise, as we do, it is an essential part of financial risk management both nationally and locally,’ says Mr Flory.